Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The management of BRCA1 and BRCA2 carriers in Singapore.

Chinese clinical oncology - 1 Oct 2020

Chiang Jianbang, Ngeow Joanne

Abstract excerpt

Singapore is a densely populated small island nation, with a multiethnic and multireligious population. Cancer is the leading cause of death in Singapore. The population is well educated and coupled with greater awareness, there is an increasing demand for genetic testing for hereditary cancer syndromes. In Singapore, the Singapore Cancer Action Network (SCAN) guidelines for referral for genetic testing serves as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Singapore

Source

Identifiers

PMID: 32819113
DOI: 10.21037/cco-20-104

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The management of BRCA1 and BRCA2 carriers in Singapore.PMID 32819113Read ↗

Current practices and challenges in genetic testing and counseling for women with breast and ovarian cancer in AsiaSemantic proximity Read ↗

Understanding cancer predisposition in Singapore: What's next.Semantic proximity Read ↗

Risk management adherence following genetic testing for hereditary cancer syndromes: a Singaporean experience.Semantic proximity Read ↗

Cascade testing for hereditary cancer in Singapore: how population genomics help guide clinical policy.Semantic proximity Read ↗

Understanding shared and sex-specific considerations in hereditary breast and ovarian cancer (HBOC) testing decision-making in Singapore.Semantic proximity Read ↗

Implementing Reproductive Carrier Screening to Include Diverse Asian Populations: Insights from SingaporeSemantic proximity Read ↗

A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies.Semantic proximity Read ↗

Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history.Semantic proximity Read ↗

Cohort profile: The Singapore Breast Cancer Cohort (SGBCC), a multi-center breast cancer cohort for evaluation of phenotypic risk factors and genetic markers.Semantic proximity Read ↗

Factors shaping at-risk individuals' decisions to undergo genetic testing for cancer in Asia.Semantic proximity Read ↗

Age-specific breast and ovarian cancer risks associated with germline BRCA1 or BRCA2 pathogenic variants – an Asian study of 572 familiesSemantic proximity Read ↗

Current Status of the Management of Hereditary Breast and Ovarian Cancer in Asia: First Report by the Asian BRCA ConsortiumSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.